Loading...
Loading chart...





The current price of ICVX is 0 USD — it has increased 0 % in the last trading day.
Icosavax Inc is a biopharmaceutical company. It is committed towards developing safe and effective vaccines against infectious diseases against infectious diseases, with an initial focus on life-threatening respiratory diseases.
Wall Street analysts forecast ICVX stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for ICVX is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Icosavax, Inc. revenue for the last quarter amounts to NaN USD, decreased % YoY.
Icosavax, Inc.. EPS for the last quarter amounts to USD, decreased % YoY.
Icosavax, Inc. (ICVX) has 60 emplpoyees as of February 10 2026.
Today ICVX has the market capitalization of 769.04M USD.